ACTRN12616001256460
Completed
未知
Online Treatment of Food Cravings in Overweight and Obese Adults using Emotional Freedom Techniques
Bond University0 sites120 target enrollmentSeptember 8, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bond University
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years and over
- •Body Mass Index greater than 25 (overweight)
- •Access to internet, email
Exclusion Criteria
- •Body Mass Index in healthy range, or underweight
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Efficacy and Safety of Sotagliflozin versus Placebo in Subjects with Type 2 Diabetes Mellitus who have inadequate glycemic control while Taking Insulin Alone or with Other Oral Antidiabetic AgentsType 2 diabetes mellitusMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2016-001804-43-BGSanofi-aventis Recherche & Développement571
Active, not recruiting
Not Applicable
Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects with Non-malignant Chronic Pain Receiving Opioid TherapyEUCTR2013-002948-91-ATShionogi Inc.540
Active, not recruiting
Phase 1
GRAVITI - A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately to Severely Active Crohn's DiseaseModerately to Severely Active Crohn's DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Immune System Diseases [C20]CTIS2023-504737-41-00Janssen - Cilag International510
Active, not recruiting
Phase 1
Evaluation of Dupilumab in Children with Uncontrolled Asthma (Liberty Asthma Voyage)EUCTR2016-001607-23-ITSanofi-Aventis Recherche & Développement838
Active, not recruiting
Phase 1
Pivotal study to assess the efficacy, safety and tolerability of dupilumab in patients with moderate-tosevere COPD with Type 2 inflammation (BOREAS)Chronic obstructive pulmonary diseaseMedDRA version: 21.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2018-001953-28-ROSanofi-aventis Recherche & Développement2,054